Morepen Laboratories Limited (BOM:500288)
India · Delayed Price · Currency is INR 89.83
+5.61 (6.66%)
At close: Aug 17, 2026
Morepen Laboratories Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 19,506 | 18,057 | 18,116 | 16,904 | 14,220 | 15,558 |
Revenue Growth | 9.49% | -0.33% | 7.17% | 18.88% | -8.60% | 29.87% |
Gross Profit Gross Profit Growth | 7,237 | 6,374 | 6,262 | 6,047 | 4,470 | 4,947 |
Operating Income Operating Income Growth | 1,482 | 891.94 | 1,451 | 1,252 | 560.79 | 1,180 |
Net Income Net Income Growth | 1,405 | 948.77 | 1,180 | 961.6 | 386.75 | 1,017 |
Earnings Per Share EPS Growth | 2.55 | 1.73 | 2.20 | 1.88 | 0.77 | 1.96 |
EPS Growth | 49.69% | -21.36% | 17.02% | 144.16% | -60.71% | -8.84% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
United States of America United States of America Growth | 1,207 | 1,574 | 879.38 | 1,007 |
Rest of World Rest of World Growth | 5,896 | 4,822 | 4,761 | 4,582 |
India India Growth | 10,935 | 10,425 | 8,499 | 9,827 |
Total Total Growth | 18,037 | 16,821 | 14,140 | 15,416 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 916.99 | 916.99 | 1,052 | 169.45 | 216.66 | 158.03 |
Total Debt Total Debt Growth | 2,079 | 2,079 | 1,051 | 289.99 | 251.64 | 1,332 |
Net Cash (Debt) Net Cash Growth | -1,162 | -1,162 | 0.93 | -120.54 | -34.98 | -1,174 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -2.11 | -2.12 | 0.00 | -0.24 | -0.07 | -2.26 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 326.42 | 320.57 | 733.75 | -911.71 | -602.4 |
Capital Expenditures CapEx Growth | - | -855.23 | -1,240 | -713.81 | -356.21 | -454.46 |
Free Cash Flow Free Cash Flow Growth | - | -528.81 | -919.76 | 19.94 | -1,268 | -1,057 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 37.10% | 35.30% | 34.57% | 35.77% | 31.44% | 31.80% |
Operating Margin | 7.60% | 4.94% | 8.01% | 7.40% | 3.94% | 7.58% |
Pretax Margin | 9.17% | 6.64% | 8.56% | 8.01% | 3.92% | 8.14% |
Profit Margin | 7.20% | 5.25% | 6.51% | 5.69% | 2.72% | 6.54% |
FCF Margin | - | -2.93% | -5.08% | 0.12% | -8.92% | -6.79% |
| Fiscal Year | Current | FY 2026 | FY 2025 |
|---|---|---|---|
| Period Ending | Aug '26 Aug 17, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 |
Dividend Per Share Dividend Per Share Growth | 0.200 | 0.200 | 0.200 |
Dividend Per Share Growth | 0% | 0% | - |
Dividend Yield | 0.24% | 0.59% | 0.42% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 17, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 33.02 | 19.52 | 22.22 | 22.36 | 33.94 | 17.20 |
P/FCF Ratio | - | - | - | 1078.33 | - | - |
PS Ratio | 2.37 | 1.03 | 1.45 | 1.27 | 0.92 | 1.12 |